Regenerative Medical Technology Group Inc. (RMTG)

Market Cap	874.05K -2.0%
Revenue (ttm)	9.41M +94.3%
Net Income	-8.82M
EPS	-0.68
Shares Out	14.96M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	28,000
Open	0.0664
Previous Close	0.0645
Day's Range	0.0600 - 0.0664
52-Week Range	0.0189 - 0.1250
Beta	1.22
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 16, 2026

About RMTG

Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and solutions. Further, it provides solutions from cli...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: RMTG

Financial Performance

In 2025, RMTG's revenue was $5.10 million, an increase of 24.17% compared to the previous year's $4.11 million. Losses were -$7.81 million, 40.4% more than in 2024.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 29, 2026

Data Sources Report a data error